Abbonarsi

Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana - 08/07/21

Doi : 10.1016/j.jpag.2021.03.005 
Drisana Henry, MD, MPH 1, , Sarah Wood, MD, MSHP 1, 2, 3, 4, Neo Moshashane, BA 5, 6, Kehumile Ramontshonyana, BA 5, 6, Christina Amutah, BA 3, Pegah Maleki, MSW, LSW 2, Claire Howlett, BS 2, Merrian J. Brooks, DO, MS 1, 4, Aamirah Mussa, MPH 5, Dipesalema Joel, MBBChBAO, B Med Sc, MRCPI 7, Andrew P. Steenhoff, MBBCh, DCH, FCPaed 3, 4, 6, 7, Aletha Y. Akers, MD, MPH 1, 2, 3, Chelsea Morroni, MBChB, MPH, PhD 5, 6, 8
1 Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 
2 PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 
3 University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania 
4 Global Health Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 
5 Botswana-Harvard AIDS Institute Partnership 
6 Botswana-UPenn Partnership 
7 University of Botswana, Gabarone, Botswana 
8 MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, United Kingdom 

Address correspondence to: Drisana Henry, MD, MPH, Pentucket Medical, 323 Lowell St, Andover, MA 01810; Phone ((978)-783-5030.Pentucket Medical323 Lowell St, AndoverMA01810

ABSTRACT

Study Objective

Botswana has a high pregnancy rate among adolescent girls and young women (AGYW). Long-acting reversible contraceptive (LARC) use among AGYW in Botswana is low, despite its high effectiveness for preventing pregnancy. Using an implementation science framework, we assessed barriers and facilitators to LARC implementation among AGYW in Botswana.

Design

Cross-sectional mixed methods.

Setting

Gaborone, Botswana.

Participants

Twenty sexually active AGYW ages 18-24 years; 20 health system stakeholders.

Interventions

Surveys and semistructured interviews grounded in the Consolidated Framework for Implementation Research.

Main Outcome Measures

Themes reflecting barriers and facilitators of LARC implementation.

Results

The median age for AGYW was 22 (interquartile range, 21-23) years. Twenty percent were using an implant and none had ever used an intrauterine device. Barriers and facilitators of LARC implementation spanned factors at each Consolidated Framework for Implementation Research domain: (1) LARC characteristics like side effects; (2) the clinics’ inner settings, including availability of youth-friendly services; (3) characteristics of health system stakeholders, such as LARC skills, and AGYW experiences, attitudes, and beliefs about LARCs; (4) the outer setting external to clinics and Botswana's health system including reproductive health law and policy for minor adolescents; and (5) the implementation process level such as the availability of free or low-cost LARCs.

Conclusion

We identified multilevel, context-specific factors that affect LARC implementation. Our findings can inform the development of interventions to increase LARC implementation in Botswana by addressing intersecting factors across patient, clinic, health system, and sociopolitical levels, such as providing confidential services to minors and improving LARC training and supply chain pipelines.

Il testo completo di questo articolo è disponibile in PDF.

Key Words : Long-acting reversible contraceptives, LARC, Implant, IUD, Adolescent, Botswana


Mappa


 Dr. Akers has received research funding support in the past 12 months from Bayer Healthcare for an investigator-initiated grant, and the Templeton Foundation, and has been a paid consultant for the Merck HPV Advisory Board, Mylan Pharmaceuticals Women's Health Advisory Board, and for Medicines360. The remaining authors indicate no conflicts of interest.
 This work was presented, in part, as a poster on October 4, 2019, and as an oral presentation on October 10, 2020, at the Children's Hospital of Philadelphia Pediatric Global Health Conference, Philadelphia, Pennsylvania.


© 2021  Elsevier Ltd. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 34 - N° 4

P. 504-513 - agosto 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • A Rapid Review of Interventions to Prevent First Pregnancy among Adolescents and Its Applicability to Latin America
  • Fátima Estrada, Erika E. Atienzo, Lizeth Cruz-Jiménez, Lourdes Campero
| Articolo seguente Articolo seguente
  • Provider Attitudes and Practices Regarding Intrauterine System (IUS) Insertion in Adolescents With and Without Bleeding Disorders for Management of Heavy Menstrual Bleeding
  • Katherine L. O'Flynn O'Brien, Allison P. Wheeler, Claudia Borzutzky, Kristina M. Haley, Peter Kouides, Oluyemisi Adeyemi-Fowode

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.